PainChek, ASX-listed developer of a mobile pain assessment app that has been widely used in the aged care sector, is now entering the global hospital market via its latest partnership with InterSystems.
WHAT IT'S ABOUT
Through this partnership, PainChek will use the InterSystems IRIS for Health data platform to integrate with EMR systems, including InterSystems TrakCare, which manages over a...
PainChek is developing a version of its mobile pain assessment and monitoring app for non-verbal children with disabilities.
Its development has been backed by a A$392,820 grant (around $260,000) from the state government of Western Australia as part of the inaugural Innovation Seed Fund. The said fund has provided a total of A$8 million ($5.45 million) to 17 projects focused on improving the...
NOVARTIS BIOME UK ANNOUNCES SELECTION FOR HEALTHHUB 21
Novartis UK has announced the selected companies for the Novartis BIOME UK HealthHub 21 Challenge, in collaboration with KQ Labs, the data driven health accelerator of the Francis Crick Institute, and LifeArc, the charity helping to turn science into benefits for patients.
The four selected companies are Living With, Macusoft, Mendelian and...
AI isn't ready for COVID-19 prime time. A systematic review of published this week in nature machine intelligence warns that new models using machine learning to review chest radiographs and chest computed tomographies for COVID-19 have major methodical deficiencies or underlying biases.
Among the 62 published or pre-print papers outlining these approaches, the authors wrote that not a single one...
PAINCHEK ANNOUNCES CARE HOME CAMPAIGN
Responding to the NHSX pledge to give 11,000 iPads to UK care homes, AI-powered pain assessment company, PainChek, has announced a one-off campaign to help UK care homes benefit from its technology.
PainChek is offering all UK care homes a one-off unique voucher of up to £500 to cover the cost of product training for their staff so they can use the PainChek...
Australia-based AI-powered pain assessment company, PainChek, is working to raise awareness of the importance of effective assessment of pain in people with dementia.
The AI technology company has published a new report called ‘Pain and dementia: common challenges for care managers’, which investigates the relationship between pain and dementia,
The report also examines how pain affects the...
According to a paper titled Pain Management in the Elderly Population: A Review published in The Ochsner Journal in 2010, pain may be underreported because some elderly patients incorrectly believe that pain is a normal process of aging. In addition, caregivers and relatives are often the most reliable source of information. However, assessing pain levels is usually not straightforward – it can...
Australia-based PainChek, developer of the world’s first smart phone-based pain assessment and monitoring app, announced that it will be partnering with Ward Medication Management (Ward MM) to deliver the federally funded national roll-out of PainChek technology to the Australian Residential Aged Care market. Ward MM is an Australian provider of medication review and quality use of medicines...
Hot on the heels on being granted a US patent for pain assessment invention last month, Australia-based PainChek, developer of the world’s first smart phone-based pain assessment and monitoring app, has received regulatory approval from Singapore’s Health Sciences Authority (HSA) for the use of the PainChek app in the market.
PainChek has also entered a two-year license agreement with Singapore-...
Australian digital health company PainChek recently announced that the United States Patent Office has issued a Notice of Allowance for its pain assessment invention. This means that patent prosecution has been successfully completed.
The U.S. patent, when granted, gives PainChek exclusive rights to exclude others from making, using, selling or importing the invention for 20 years from the...
